Health House International gains Satipharm distribution.



Edit: Previous post incorrectly Satipharm was no longer distributing with HL Pharma. 

Health House International has entered into an agreement with Canadian company Harvest One Cannabis (TSXV: HVT; OTCQX: HRVOF) to distribute for their wholly owned subsidiary, Satipharm.

Satipharm’s CBD capsules have been available in Australia since November 2017 through their additional distribution partner, HL Pharma.

Under the new agreement, Health House will be responsible for distributing the CBD capsules to their pharmacy network while supporting health care professionals looking to prescribe the product.

Health House is a medicinal cannabis specific distribution company based in Perth, WA. Operating since early 2017, they have been distributing for Creso Pharma’s (ASX: CPH) Canadian partner, CanniMed.

Paul Mavor, CEO of Health House said, “the addition of Satipharm’s 50mg Gelpell® capsules to our range allows us to provide clinically proven, high quality CBD to customers. The capsule is a pharmaceutically elegant and convenient dosage form for those who have been prescribed CBD.”

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Blaise Bratter
Blaise Bratter is the Chief Contributor to CannabisIntel. Being involved in the Australian cannabis industry since legalisation in 2016, he is now Operations Manager for ASX listed company MGC Pharmaceuticals.

Get all the latest content delivered straight to your inbox.”